Who owns the XP PHARMA CONSULTING trademark?

The XP PHARMA CONSULTING trademark is owned by XP Pharma Consulting, LLC.

What class is the XP PHARMA CONSULTING trademark registered in?

The XP PHARMA CONSULTING trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for XP PHARMA CONSULTING?

The USPTO serial number for XP PHARMA CONSULTING is 98734584.

What is the registration number for XP PHARMA CONSULTING?

XP PHARMA CONSULTING is registered under USPTO registration number 7878519.

XPP

USPTO Trademark Record

REGISTERED

XP PHARMA CONSULTING

SN 98734584·Reg 7878519·Filed Sep 05, 2024

Owner XP Pharma Consulting, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

XP PHARMA CONSULTING (Serial No. 98734584), Registration No. 7878519, is a registered US trademark filed on Sep 05, 2024 by XP Pharma Consulting, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: August 05, 2031

Mark Intelligence

XP PHARMA CONSULTING (Reg. #7878519) is a registered US trademark that has been protecting its owner, XP Pharma Consulting, LLC, since 2024. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 05, 2024

SERIAL

98734584

REG#

7878519

REGISTERED

Aug 05, 2025

Owner

Applicant

XP Pharma Consulting, LLC

Entity

LLC

State

Address

2843 Brinker Ln, Easton, PA, 18040

Attorney

Law firm

XP Pharma Consulting, LLC

Docket

XP20240905

Address

2843 Brinker Ln, Easton, PA 18040, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 05, 2024

Serial Number98734584

Registration No.7878519

Registration DateAug 05, 2025

Status DateAug 05, 2025

Published for OppositionJun 17, 2025

Mark TypeStylized characters

Attorney DocketXP20240905

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 24, 2024

First use in commerce: Feb 24, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

24 events

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 26, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 26, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 26, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 05, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

REGISTERED-PRINCIPAL REGISTER

Aug 05, 2025

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jun 17, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 17, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 11, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 15, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Apr 16, 2025

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

TEAS VOLUNTARY AMENDMENT RECEIVED

Apr 16, 2025

TEAS VOLUNTARY AMENDMENT RECEIVED

EXAMINER'S AMENDMENT ENTERED

Apr 15, 2025

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 15, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Apr 15, 2025

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 15, 2025

EXAMINERS AMENDMENT -WRITTEN

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 10, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 09, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 09, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 01, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Apr 01, 2025

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Apr 01, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Mar 17, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 15, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 05, 2024

NEW APPLICATION ENTERED

XP PHARMA CONSULTING

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Resources

Company